CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. Key findings of the study
2.2. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Top player positioning
3.5. Market dynamics
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
3.6. COVID-19 Impact Analysis on the market

CHAPTER 4: GENERAL ANESTHESIA DRUGS MARKET, BY Type of Drugs

4.1 Overview
4.1.1 Market size and forecast
4.2 Propofol
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by Country
4.3 Sevoflurane
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by Country
4.4 Desflurane
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by Country
4.5 Others
4.5.1 Key market trends, growth factors and opportunities
4.5.2 Market size and forecast, by region
4.5.3 Market analysis by Country

CHAPTER 5: GENERAL ANESTHESIA DRUGS MARKET, by Route of Administration

5.1 Overview
5.1.1 Market size and forecast
5.2 Intravenous
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by Country
5.3 Inhalation
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by Country

CHAPTER 6: GENERAL ANESTHESIA DRUGS MARKET, by Surgery Type

6.1 Overview
6.1.1 Market size and forecast
6.2 Knee and hip replacements
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by Country
6.3 Heart surgeries
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by Country
6.4 Cancer surgery
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by Country
6.5 General surgery
6.5.1 Key market trends, growth factors and opportunities
6.5.2 Market size and forecast, by region
6.5.3 Market analysis by Country

CHAPTER 7: GENERAL ANESTHESIA DRUGS MARKET, by End-user

7.1 Overview
7.1.1 Market size and forecast
7.2 Hospital
7.2.1 Key market trends, growth factors and opportunities
7.2.2 Market size and forecast, by region
7.2.3 Market analysis by Country
7.3 Ambulatory surgical centers
7.3.1 Key market trends, growth factors and opportunities
7.3.2 Market size and forecast, by region
7.3.3 Market analysis by Country

CHAPTER 8: GENERAL ANESTHESIA DRUGS MARKET, BY REGION

8.1 Overview
8.1.1 Market size and forecast
8.2 North America
8.2.1 Key trends and opportunities
8.2.2 North America Market size and forecast, by Type of Drugs
8.2.3 North America Market size and forecast, by Route of Administration
8.2.4 North America Market size and forecast, by Surgery Type
8.2.5 North America Market size and forecast, by End-user
8.2.6 North America Market size and forecast, by Country
8.2.6.1 U.S.
8.2.6.1.1 Market size and forecast, by Type of Drugs
8.2.6.1.2 Market size and forecast, by Route of Administration
8.2.6.1.3 Market size and forecast, by Surgery Type
8.2.6.1.4 Market size and forecast, by End-user
8.2.6.2 Canada
8.2.6.2.1 Market size and forecast, by Type of Drugs
8.2.6.2.2 Market size and forecast, by Route of Administration
8.2.6.2.3 Market size and forecast, by Surgery Type
8.2.6.2.4 Market size and forecast, by End-user
8.2.6.3 Mexico
8.2.6.3.1 Market size and forecast, by Type of Drugs
8.2.6.3.2 Market size and forecast, by Route of Administration
8.2.6.3.3 Market size and forecast, by Surgery Type
8.2.6.3.4 Market size and forecast, by End-user
8.3 Europe
8.3.1 Key trends and opportunities
8.3.2 Europe Market size and forecast, by Type of Drugs
8.3.3 Europe Market size and forecast, by Route of Administration
8.3.4 Europe Market size and forecast, by Surgery Type
8.3.5 Europe Market size and forecast, by End-user
8.3.6 Europe Market size and forecast, by Country
8.3.6.1 Germany
8.3.6.1.1 Market size and forecast, by Type of Drugs
8.3.6.1.2 Market size and forecast, by Route of Administration
8.3.6.1.3 Market size and forecast, by Surgery Type
8.3.6.1.4 Market size and forecast, by End-user
8.3.6.2 France
8.3.6.2.1 Market size and forecast, by Type of Drugs
8.3.6.2.2 Market size and forecast, by Route of Administration
8.3.6.2.3 Market size and forecast, by Surgery Type
8.3.6.2.4 Market size and forecast, by End-user
8.3.6.3 U.K.
8.3.6.3.1 Market size and forecast, by Type of Drugs
8.3.6.3.2 Market size and forecast, by Route of Administration
8.3.6.3.3 Market size and forecast, by Surgery Type
8.3.6.3.4 Market size and forecast, by End-user
8.3.6.4 Italy
8.3.6.4.1 Market size and forecast, by Type of Drugs
8.3.6.4.2 Market size and forecast, by Route of Administration
8.3.6.4.3 Market size and forecast, by Surgery Type
8.3.6.4.4 Market size and forecast, by End-user
8.3.6.5 Spain
8.3.6.5.1 Market size and forecast, by Type of Drugs
8.3.6.5.2 Market size and forecast, by Route of Administration
8.3.6.5.3 Market size and forecast, by Surgery Type
8.3.6.5.4 Market size and forecast, by End-user
8.3.6.6 Rest of Europe
8.3.6.6.1 Market size and forecast, by Type of Drugs
8.3.6.6.2 Market size and forecast, by Route of Administration
8.3.6.6.3 Market size and forecast, by Surgery Type
8.3.6.6.4 Market size and forecast, by End-user
8.4 Asia-Pacific
8.4.1 Key trends and opportunities
8.4.2 Asia-Pacific Market size and forecast, by Type of Drugs
8.4.3 Asia-Pacific Market size and forecast, by Route of Administration
8.4.4 Asia-Pacific Market size and forecast, by Surgery Type
8.4.5 Asia-Pacific Market size and forecast, by End-user
8.4.6 Asia-Pacific Market size and forecast, by Country
8.4.6.1 China
8.4.6.1.1 Market size and forecast, by Type of Drugs
8.4.6.1.2 Market size and forecast, by Route of Administration
8.4.6.1.3 Market size and forecast, by Surgery Type
8.4.6.1.4 Market size and forecast, by End-user
8.4.6.2 Japan
8.4.6.2.1 Market size and forecast, by Type of Drugs
8.4.6.2.2 Market size and forecast, by Route of Administration
8.4.6.2.3 Market size and forecast, by Surgery Type
8.4.6.2.4 Market size and forecast, by End-user
8.4.6.3 India
8.4.6.3.1 Market size and forecast, by Type of Drugs
8.4.6.3.2 Market size and forecast, by Route of Administration
8.4.6.3.3 Market size and forecast, by Surgery Type
8.4.6.3.4 Market size and forecast, by End-user
8.4.6.4 Australia
8.4.6.4.1 Market size and forecast, by Type of Drugs
8.4.6.4.2 Market size and forecast, by Route of Administration
8.4.6.4.3 Market size and forecast, by Surgery Type
8.4.6.4.4 Market size and forecast, by End-user
8.4.6.5 South Korea
8.4.6.5.1 Market size and forecast, by Type of Drugs
8.4.6.5.2 Market size and forecast, by Route of Administration
8.4.6.5.3 Market size and forecast, by Surgery Type
8.4.6.5.4 Market size and forecast, by End-user
8.4.6.6 Rest of Asia-Pacific
8.4.6.6.1 Market size and forecast, by Type of Drugs
8.4.6.6.2 Market size and forecast, by Route of Administration
8.4.6.6.3 Market size and forecast, by Surgery Type
8.4.6.6.4 Market size and forecast, by End-user
8.5 LAMEA
8.5.1 Key trends and opportunities
8.5.2 LAMEA Market size and forecast, by Type of Drugs
8.5.3 LAMEA Market size and forecast, by Route of Administration
8.5.4 LAMEA Market size and forecast, by Surgery Type
8.5.5 LAMEA Market size and forecast, by End-user
8.5.6 LAMEA Market size and forecast, by Country
8.5.6.1 Brazil
8.5.6.1.1 Market size and forecast, by Type of Drugs
8.5.6.1.2 Market size and forecast, by Route of Administration
8.5.6.1.3 Market size and forecast, by Surgery Type
8.5.6.1.4 Market size and forecast, by End-user
8.5.6.2 Saudi Arabia
8.5.6.2.1 Market size and forecast, by Type of Drugs
8.5.6.2.2 Market size and forecast, by Route of Administration
8.5.6.2.3 Market size and forecast, by Surgery Type
8.5.6.2.4 Market size and forecast, by End-user
8.5.6.3 South Africa
8.5.6.3.1 Market size and forecast, by Type of Drugs
8.5.6.3.2 Market size and forecast, by Route of Administration
8.5.6.3.3 Market size and forecast, by Surgery Type
8.5.6.3.4 Market size and forecast, by End-user
8.5.6.4 Rest of LAMEA
8.5.6.4.1 Market size and forecast, by Type of Drugs
8.5.6.4.2 Market size and forecast, by Route of Administration
8.5.6.4.3 Market size and forecast, by Surgery Type
8.5.6.4.4 Market size and forecast, by End-user

CHAPTER 9: COMPANY LANDSCAPE

9.1. Introduction
9.2. Top winning strategies
9.3. Product Mapping of Top 10 Players
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Key developments

CHAPTER 10: COMPANY PROFILES

10.1 B. Braun Melsungen
10.1.1 Company overview
10.1.2 Company snapshot
10.1.3 Operating business segments
10.1.4 Product portfolio
10.1.5 Business performance
10.1.6 Key strategic moves and developments
10.2 Baxter International Inc.
10.2.1 Company overview
10.2.2 Company snapshot
10.2.3 Operating business segments
10.2.4 Product portfolio
10.2.5 Business performance
10.2.6 Key strategic moves and developments
10.3 Fresenius SE and Co. KGaA
10.3.1 Company overview
10.3.2 Company snapshot
10.3.3 Operating business segments
10.3.4 Product portfolio
10.3.5 Business performance
10.3.6 Key strategic moves and developments
10.4 Hikma Pharmaceuticals plc
10.4.1 Company overview
10.4.2 Company snapshot
10.4.3 Operating business segments
10.4.4 Product portfolio
10.4.5 Business performance
10.4.6 Key strategic moves and developments
10.5 Paion AG
10.5.1 Company overview
10.5.2 Company snapshot
10.5.3 Operating business segments
10.5.4 Product portfolio
10.5.5 Business performance
10.5.6 Key strategic moves and developments
10.6 Pfizer Inc.
10.6.1 Company overview
10.6.2 Company snapshot
10.6.3 Operating business segments
10.6.4 Product portfolio
10.6.5 Business performance
10.6.6 Key strategic moves and developments
10.7 Abbott Laboratories
10.7.1 Company overview
10.7.2 Company snapshot
10.7.3 Operating business segments
10.7.4 Product portfolio
10.7.5 Business performance
10.7.6 Key strategic moves and developments
10.8 Abbvie Inc
10.8.1 Company overview
10.8.2 Company snapshot
10.8.3 Operating business segments
10.8.4 Product portfolio
10.8.5 Business performance
10.8.6 Key strategic moves and developments
10.9 AstraZeneca plc
10.9.1 Company overview
10.9.2 Company snapshot
10.9.3 Operating business segments
10.9.4 Product portfolio
10.9.5 Business performance
10.9.6 Key strategic moves and developments
10.10 Avet Pharmaceuticals Inc
10.10.1 Company overview
10.10.2 Company snapshot
10.10.3 Operating business segments
10.10.4 Product portfolio
10.10.5 Business performance
10.10.6 Key strategic moves and developments